Low doses of interferon alpha result in more effective clinical natural killer cell activation.

To define critical parameters concerning interferon (IFN) effects upon natural killer (NK) cells in vivo, we gave cancer patients serial weekly intramuscular injections of purified lymphoblastoid IFN in six doses ranging from 10(5) to 3 X 10(7) U. Dose sequences were determined by randomly allocatin...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Invest
Egile Nagusiak:	Edwards, B S, Merritt, J A, Fuhlbrigge, R C, Borden, E C
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Clinical Investigation 1985
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC425547/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/4008643/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111905
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!